CSIMarket
 
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 
 
Price: $1.8300 $-0.09 -4.687%
Day's High: $1.995 Week Perf: -12.44 %
Day's Low: $ 1.80 30 Day Perf: -8.73 %
Volume (M): 69 52 Wk High: $ 4.28
Volume (M$): $ 126 52 Wk Avg: $2.31
Open: $1.96 52 Wk Low: $1.32



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 22
 Cash Flow (TTM) (Millions $) 11
 Capital Exp. (TTM) (Millions $) 0

Purple Biotech Ltd


   Company Address: 4 Oppenheimer Street Rehovot 7670104
   Company Phone Number: 3-933-3121   Stock Exchange / Ticker: NASDAQ PPBT
   PPBT is expected to report next financial results on March 02, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Security Federal Corporation

Outstanding Earnings per Share Increase by 62.16 % at the Regional Banks company during the most recent fiscal period

Focusing on the most recent fiscal period income jumped by 62.16 % to $1.01 per share, followed by Sales increase of 14.164 % to $13.11 millions, compared with the prior year period.

Aptose Biosciences Inc

The Biotechnology & Pharmaceuticals company caused great story for the shareholders, displaying an important growth in fourth quarter of 2022 with operating loss of $-10.403 millions

Following the large companies in the Biotechnology & Pharmaceuticals industry, some smaller entities are reporting the respective results. Aptose Biosciences Inc said it has announced operating loss of $-10.403 millions, for the fourth quarter of 2022.

Meta Materials Inc

Evanescence of Deficit at MMAT over the most recent fiscal period

For the most recent fiscal period company decreased a loss per share of $-0.03 per share compare to $-0.22 a year prior and Income per Share improved from $-0.07 per share from the prior reporting period.

Sales faded by -49.855 % to $1.45 millions from $2.88 millions in the comparable reporting period a year prior and sequentially Sales Tumbled by -41.135 % from $2.46 millions.

Aslan Pharmaceuticals Limited

The ascending company from the Biotechnology & Pharmaceuticals sector the ASLN released the fiscal fourth quarter of 2022, results

As the earnings season of the October to December 31 2022 season continues, many entities have declared the results. Some of them, have been multiple businesses in the Biotechnology & Pharmaceuticals industry. As well as, now, ASLN announced operating shortfall of $-47.882487 millions, for the fiscal three months closing Dec 31 2022.

First Seacoast Bancorp Inc

Deficit on Weak Sales in the fourth quarter of 2022 earnings season

For the fourth quarter of 2022 earnings season First Seacoast Bancorp Inc slipped into loss of $-0.28 per share compare to $0.07 a year prior and earnings per share fell from $0.08 per share from the prior reporting period.

Sales receded extensively by -13.143 % to $3.23 millions from $3.71 millions in the comparable reporting period a year prior and sequentially Sales fell by -23.488 % from $4.22 millions.






 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

APD's Profile

Stock Price

APD's Financials

Business Description

Fundamentals

Charts & Quotes

APD's News

Suppliers

APD's Competitors

Customers & Markets

Economic Indicators

APD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071